Man Group plc Has $1.88 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Man Group plc raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 438.6% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 29,300 shares of the company’s stock after acquiring an additional 23,860 shares during the period. Man Group plc’s holdings in GE HealthCare Technologies were worth $1,875,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of the company. Banque Cantonale Vaudoise increased its stake in GE HealthCare Technologies by 16,539.1% in the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after buying an additional 25,801 shares during the last quarter. Allstate Corp increased its position in GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after buying an additional 16,365 shares during the last quarter. Auto Owners Insurance Co lifted its stake in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the last quarter. Northside Capital Management LLC lifted its holdings in GE HealthCare Technologies by 26.5% during the 2nd quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock worth $15,485,000 after purchasing an additional 50,634 shares during the last quarter. Finally, Boston Partners lifted its holdings in shares of GE HealthCare Technologies by 21.7% during the fourth quarter. Boston Partners now owns 4,659,562 shares of the company’s stock worth $382,223,000 after buying an additional 830,626 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Citigroup raised their price objective on GE HealthCare Technologies from $69.00 to $75.00 and gave the stock a “neutral” rating in a research note on Thursday, July 30th. Royal Bank Of Canada initiated coverage on GE HealthCare Technologies in a research report on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 target price for the company. Zacks Research raised GE HealthCare Technologies from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. BTIG Research reaffirmed a “buy” rating and issued a $79.00 price target on shares of GE HealthCare Technologies in a research note on Wednesday, August 19th. Finally, Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, July 30th. Ten equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $77.73.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $70.42 on Wednesday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The stock has a market capitalization of $31.81 billion, a P/E ratio of 16.15, a price-to-earnings-growth ratio of 1.88 and a beta of 0.70. The stock has a fifty day moving average of $68.02 and a 200-day moving average of $69.14.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The business had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period last year, the firm posted $1.06 earnings per share. GE HealthCare Technologies’s revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 24th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.21%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.